All Stories

  1. In silico approaches for investigating the binding propensity of apigenin and luteolin against class I HDAC isoforms

    Article • Future Medicinal Chemistry, July 2018, Future Science

    Dr shabir ahmad ganai, Dr Shabir Ahmad Ganai

  2. Designing Isoform-selective Inhibitors Against Classical HDACs for Effective Anticancer Therapy: Insight and Perspectives from In Silico

    Article • Current Drug Targets, April 2018, Bentham Science Publishers

    Dr shabir ahmad ganai, Dr Shabir Ahmad Ganai

  3. Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention

    Article • Current Drug Targets, April 2018, Bentham Science Publishers

    Dr shabir ahmad ganai, Dr Shabir Ahmad Ganai

  4. Small-molecule Modulation of HDAC6 Activity: The Propitious Therapeutic Strategy to Vanquish Neurodegenerative Disorders

    Article • Current Medicinal Chemistry, December 2017, Bentham Science Publishers

    Dr shabir ahmad ganai, Dr Shabir Ahmad Ganai

  5. Novel Approaches Towards Designing of Isoform-Selective Inhibitors Against Class II Histone Deacetylases: The Acute Requirement for Targetted Anticancer Therapy

    Article • Current Topics in Medicinal Chemistry, June 2016, Bentham Science Publishers

    Dr shabir ahmad ganai, Dr Shabir Ahmad Ganai

  6. Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity

    Article • Current Topics in Medicinal Chemistry, October 2015, Bentham Science Publishers

    Dr shabir ahmad ganai, Dr Shabir Ahmad Ganai